![Los inversores le pegan un empujón al S&P 500 ¡Hartos de seguir en las mismas con el Dax 40 y el Nasdaq 100! | FXMAG Los inversores le pegan un empujón al S&P 500 ¡Hartos de seguir en las mismas con el Dax 40 y el Nasdaq 100! | FXMAG](https://es.fxmag.com/uploads/content/2021-12/los-inversores-le-pegan-un-empujon-al-sp-500-hartos-de-seguir-en-las-mismas-con-el-dax-40-y-el-nasdaq-100-2.png)
Los inversores le pegan un empujón al S&P 500 ¡Hartos de seguir en las mismas con el Dax 40 y el Nasdaq 100! | FXMAG
![Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is](https://pbs.twimg.com/media/FYrgbtKWQAgAop7.jpg:large)
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
Teva Pharmaceutical Industries (NYSE:TEVA) investors are sitting on a loss of 76% if they invested five years ago
![2nd Annual NASDAQ TASE Israeli Investor Conference Dan Suesskind, CFO Teva Pharmaceutical Industries Ltd. November 27, ppt download 2nd Annual NASDAQ TASE Israeli Investor Conference Dan Suesskind, CFO Teva Pharmaceutical Industries Ltd. November 27, ppt download](https://images.slideplayer.com/22/6352607/slides/slide_33.jpg)